期刊
DRUG TESTING AND ANALYSIS
卷 1, 期 9-10, 页码 412-418出版社
WILEY
DOI: 10.1002/dta.58
关键词
anabolic; clinical trial; growth hormone; lipolytic; performance
资金
- World Anti-Doping Agency
- US Anti-Doping Agency
Growth hormone (GH) was first isolated from the pituitary gland in the 1940s. It is believed that athletes have been abusing GH for its anabolic and lipolytic effects since the early 1980s, at least a decade before endocrinologists began to treat adults with GH deficiency. Most of our knowledge about GH abuse is anecdotal but a number of high-profile athletes have admitted using GH. Despite its widespread abuse, there is debate about whether GH is ergogenic. Indeed most scientific studies have not shown a performance enhancing effect. This review will address why this discrepancy of opinion between athletes and scientists exists and why the author believes that the scientists are wrong. Copyright (C) 2009 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据